New

Molecular (PCR)

AccuPlex™ SARS-CoV-2, Flu A/B and RSV Verification Panel

Material Number 0505-0183
Size 4 x 3 mL
Inventory Status In Stock
Unit EA

To expedite your order, if you already have an e-commerce account, please proceed with placing your order via our website. If you do not currently have an eCommerce account, please email your purchase order to CustomerService@Seracare.com or contact us at 1.800.676.1881. If you need to set us up as a new vendor, please reference our W-9.

The AccuPlex™ SARS-CoV-2, Flu A/B and RSV Verification Panel is formulated for use with multiplex test methods that can detect SARS-CoV-2, flu A/B and respiratory syncytial virus (RSV). Included are three different concentrations of positive reference material as well as negative reference material directed against the human RNase P gene. The panel is optimized for assay verification at installation by documenting test performance along the assay’s range enabling laboratories to establish lower limits of detection, perform assay comparisons, and evaluate staff proficiency. Product is released using the US CDC Influenza SARS-CoV-2 (Flu-SC2) Multiplex Assay and Cepheid GeneXpert® Xpress SARS-CoV-2 and Flu/RSV Assays.

Not for In Vitro Diagnostic Use. Research Use Only

Click here for bulk quantities or custom requests


LGC SeraCare’s SARS-CoV-2, Flu A/B and RSV AccuPlex solution:

  • Non-infectious and replication deficient, enables safe handling in contrast to viral samples
  • Fully-extractable with a real viral protein coat; superior to “naked” transcribed RNA
  • 2 year stability at 2 - 8°C

AccuPlex™ Quality Solutions for Respiratory Disease Diagnostics - Product Sheet

Doc type
Product Sheet

AccuPlex SDS-ACRN-16